The FDA Warning Letter Tracker: Which GLP-1 Providers Have Been Flagged
FDA warning letters are public record, and they're one of the more useful signals for evaluating a provider — but almost nobody actually checks them before signing up. Here's what they mean and how to think about a provider that's received one.
What a warning letter actually is
An FDA warning letter is a formal notice that the agency believes a company has violated FDA regulations — commonly for misbranding, unsubstantiated claims, or manufacturing/quality issues. It's a documented, public regulatory action, not a rumor or a competitor's accusation.
Why this matters for a provider you're evaluating
A warning letter doesn't automatically mean a provider is unsafe to use today — letters address specific issues at a specific point in time, and companies can and do correct the underlying problem. But it does mean that provider had a documented compliance issue serious enough for federal action, which is relevant context you deserve to have before choosing them over an alternative with a clean record.
How to actually check this yourself
The FDA maintains a public, searchable warning letter database at fda.gov. Before committing to any telehealth provider, a quick search of the company name takes a few minutes and gives you documented, unbiased information — not marketing copy, not a competitor's spin.
Embody From consult
Injectable semaglutide with no current FDA warning letters on record.
Visit Embody →Paid linkThe bottom line
A clean regulatory record isn't a guarantee of quality, and a past warning letter isn't automatically disqualifying — but this is public, verifiable information that takes minutes to check and that most people never do. We think you should.